A potential prognostic long non-coding RNA signature to predict metastasis-free survival of breast cancer patients

Long non-coding RNAs (lncRNAs) have been implicated in a variety of biological processes, and dysregulated lncRNAs have demonstrated potential roles as biomarkers and therapeutic targets for cancer prognosis and treatment. In this study, by repurposing microarray probes, we analyzed lncRNA expression profiles of 916 breast cancer patients from the Gene Expression Omnibus (GEO). Nine lncRNAs were identified to be significantly associated with metastasis-free survival (MFS) in the training dataset of 254 patients using the Cox proportional hazards regression model. These nine lncRNAs were then combined to form a single prognostic signature for predicting metastatic risk in breast cancer patients that was able to classify patients in the training dataset into high- and low-risk subgroups with significantly different MFSs (median 2.4 years versus 3.0 years, log-rank test p < 0.001). This nine-lncRNA signature was similarly effective for prognosis in a testing dataset and two independent datasets. Further analysis showed that the predictive ability of the signature was independent of clinical variables, including age, ER status, ESR1 status and ERBB2 status. Our results indicated that lncRNA signature could be a useful prognostic marker to predict metastatic risk in breast cancer patients and may improve upon our understanding of the molecular mechanisms underlying breast cancer metastasis.

[1]  Jin Meng,et al.  A four-long non-coding RNA signature in predicting breast cancer survival , 2014, Journal of experimental & clinical cancer research : CR.

[2]  Mads Thomassen,et al.  Long non-coding RNA expression profiles predict metastasis in lymph node-negative breast cancer independently of traditional prognostic markers , 2015, Breast Cancer Research.

[3]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[4]  Xiaoqin Zhang,et al.  A long non-coding RNA signature in glioblastoma multiforme predicts survival , 2013, Neurobiology of Disease.

[5]  Fang Zhou,et al.  LncRNA profile study reveals a three-lncRNA signature associated with the survival of patients with oesophageal squamous cell carcinoma , 2014, Gut.

[6]  T. Speed,et al.  Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.

[7]  Brad T. Sherman,et al.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.

[8]  Wing Hung Wong,et al.  SeqMap: mapping massive amount of oligonucleotides to the genome , 2008, Bioinform..

[9]  A. Chambers,et al.  Gene signatures of breast cancer progression and metastasis , 2011, Breast Cancer Research.

[10]  Andrew H. Beck,et al.  Transcriptional profiling of long non-coding RNAs and novel transcribed regions across a diverse panel of archived human cancers , 2012, Genome Biology.

[11]  Zhen Su,et al.  Integrative genomic analyses reveal clinically relevant long non-coding RNA in human cancer , 2013 .

[12]  Howard Y. Chang,et al.  Long noncoding RNA HOTAIR reprograms chromatin state to promote cancer metastasis , 2010, Nature.

[13]  Howard Y. Chang,et al.  Long intergenic noncoding RNAs: new links in cancer progression. , 2011, Cancer research.

[14]  Gary D Bader,et al.  Enrichment Map: A Network-Based Method for Gene-Set Enrichment Visualization and Interpretation , 2010, PloS one.

[15]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumours , 2013 .

[16]  Yudong D. He,et al.  A Gene-Expression Signature as a Predictor of Survival in Breast Cancer , 2002 .

[17]  J. Mattick,et al.  Long non-coding RNAs: insights into functions , 2009, Nature Reviews Genetics.

[18]  Y Wang,et al.  Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.

[19]  J. Reinitz,et al.  A Prognostic Gene Signature for Metastasis-Free Survival of Triple Negative Breast Cancer Patients , 2013, PloS one.

[20]  Jiancheng Luo,et al.  Comprehensive characterization of cancer subtype associated long non-coding RNAs and their clinical implications , 2014, Scientific Reports.

[21]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[22]  J. Peterse,et al.  Breast cancer metastasis: markers and models , 2005, Nature Reviews Cancer.

[23]  A. Jemal,et al.  Breast Cancer Statistics , 2013 .

[24]  Hemant Ishwaran,et al.  Signalling pathway for RKIP and Let‐7 regulates and predicts metastatic breast cancer , 2011, The EMBO journal.

[25]  J. Foekens,et al.  Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer , 2005, The Lancet.

[26]  H. Fröhlich,et al.  Network Based Consensus Gene Signatures for Biomarker Discovery in Breast Cancer , 2011, PloS one.

[27]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumors , 2012, Nature.

[28]  Carolyn J. Brown,et al.  The functional role of long non-coding RNA in human carcinomas , 2011, Molecular Cancer.

[29]  G. Hortobagyi,et al.  Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  Denise P Barlow,et al.  Gene regulation by the act of long non-coding RNA transcription , 2013, BMC Biology.

[31]  T. Crook,et al.  The p53 pathway in breast cancer , 2002, Breast Cancer Research.

[32]  A. Jemal,et al.  Breast cancer statistics, 2013 , 2014, CA: a cancer journal for clinicians.

[33]  Rong Yin,et al.  Long noncoding RNA: an emerging paradigm of cancer research , 2013, Tumor Biology.

[34]  David G. Knowles,et al.  The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression , 2012, Genome research.

[35]  William Stafford Noble,et al.  Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project , 2007, Nature.

[36]  Ji-Lin Wang,et al.  A long non-coding RNA signature to improve prognosis prediction of colorectal cancer , 2014, Oncotarget.

[37]  Qing-Yuan Sun,et al.  BRCA1 Is Required for Meiotic Spindle Assembly and Spindle Assembly Checkpoint Activation in Mouse Oocytes1 , 2008, Biology of reproduction.

[38]  Van,et al.  A gene-expression signature as a predictor of survival in breast cancer. , 2002, The New England journal of medicine.

[39]  Shuli Kang,et al.  Large-scale prediction of long non-coding RNA functions in a coding–non-coding gene co-expression network , 2011, Nucleic acids research.

[40]  Cole Trapnell,et al.  Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. , 2011, Genes & development.

[41]  Bronwen L. Aken,et al.  GENCODE: The reference human genome annotation for The ENCODE Project , 2012, Genome research.

[42]  R. Bernards,et al.  A gene signature for late distant metastasis in breast cancer identifies a potential mechanism of late recurrences , 2013, Molecular oncology.

[43]  Adhemar Longatto-Filho,et al.  MicroRNA expression as risk biomarker of breast cancer metastasis: a pilot retrospective case-cohort study , 2013, BMC Cancer.